Table 4. Data of oxygen saturation, neuromuscular strength and range of motion in baseline, pretreatment and posttreatment moments. Data are shown as mean (± SD).
Baseline Pretreatment Posttreatment
SmO2 Rest NVFR 62.00 (12.82) 60.95 (9.90) 66.74 (13.86)
VFR 65.37 (10.20) 62.00 (15.1) 65.74 (14.42)
After ten squats NVFR 37.74 (14.66) 36.58 (12.7) 48.47 (17.49) a,b
VFR 36.11 (16.80) 42.26 (15.6) 50.53 (16.47) a
CMJ NVFR 34.63 (4.97) 31.40 (4.97) a 33.05 (5.53) a,b
VFR 37.09 (5.89) 33.78 (6.01) a 36.23 (6.18) b
Hip joint ROM Active NVFR 27.16 (4.41) 22.63 (5.21) a 26.47 (3.95) a,b
VFR 28.21 (5.65) 22.21 (5.69) a 27.21 (5.44) a,b
Passive NVFR 30.63 (4.22) 26.11 (5.31) a 29.21 (3.90) a,b
VFR 31.89 (5.79) 26.42 (5.98) a 30.79 (6.21) a,b
Knee joint ROM Active NVFR 124.95 (3.58) 121.8 (3.26) a 123.58 (3.31) a,b
VFR 125.63 (6.59) 120.8 (5.14) a 124.26 (6.31) a,b
Passive NVFR 129.95 (5.67) 125.0 (4.13) a 126.11 (3.86) a
VFR 129.95 (6.65) 126.0 (6.08) a 128.26 (6.59) b
SmO2, muscle oxygen saturation; CMJ, countermovement jump; ROM, range of motion; SD, standard deviation.
a. Significant (p ≤ 0.05) difference with baseline measure.
b Significant (p ≤ 0.05) difference with pretreatment group.